Restoration of MPTP-induced deficits by exercise and Milmed® co-treatment

PeerJ

Volumn 2014, Issue 1, 2014, Pages

  Archer, Trevor ^a,b   Garcia, Danilo ^a,b   Fredriksson, Anders ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Network for Empowerment and Well Being   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Attenuation; Dopamine; Exercise; Locomotion; Milmed ; MPTP; Parkinsonism; Restoration; Running wheels; Total activity

Indexed keywords

1, 2, 3, 6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIPARKINSON AGENT; DOPAMINE; LEVODOPA; MILMED; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PARKINSON DISEASE; YEAST;

EID: 84907680552     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.531     Document Type: Article

References (35)

1. Aguiar Jr AS, Moreira EL, Hoeller AA, Oliveira PA, Córdova FM, Glaser V, Walz R, Cunha RA, Leal RB, Latini A, Prediger RD. 2013. Exercise attenuates levodopainduced dyskinesia in 6-hydroxydopamine-lesioned mice. Neuroscience 243:46-53 DOI 10.1016/j.neuroscience.2013.03.039.
2. Al-Jarrah M. 2013. Exercise training and rehabilitation of the brain in Parkinson's disease. Clinical Medicine Research 2(2):11-17 DOI 10.11648/j.cmr.20130202.12.
3. Archer T. 2011. Physical exercise alleviates debilities of normal aging and Alzheimer's disease. Acta Neurologica Scandinavica 123(4):221-238 DOI 10.1111/j.1600-0404.2010.01412.x.
4. Archer T, Fredriksson A. 2003. An antihypokinesic action of a2-adrenoceptors upon MPTP-induced behavior deficits in mice. Journal of Neural Transmission 110:183-200 DOI 10.1007/s00702-002-0777-5.
5. Archer T, Fredriksson A. 2006. Influence of noradrenaline denervation on MPTP-induced deficits in mice. Journal of Neural Transmission 113(9):1119-1129 DOI 10.1007/s00702-005-0402-5.
6. Archer T, Fredriksson A. 2010. Physical exercise attenuates MPTP-induced deficits in mice. Neurotoxicity Research 18:313-327 DOI 10.1007/s12640-010-9168-0.
7. Archer T, Fredriksson A. 2012. Delayed exercise-induced functional and neurochemical partial restoration following MPTP. Neurotoxicity Research 21(2):210-221 DOI 10.1007/s12640-011-9261-z.
8. Archer T, Fredriksson A. 2013a. The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice. Neurotoxicity Research 24(3):393-406 DOI 10.1007/s12640-013-9405-4.
9. Archer T, Fredriksson A. 2013b. Pharmacogenomics and personalized medicine in Parkinsonism. In: Barh D, ed. Pharmacogenomics. Berlin: Springer.
10. Archer T, Fredriksson A. 2013c. Physical exercise as intervention in Parkinsonism. In: Kostrzewa RM, ed. Handbook of neurotoxicity. New York: Springer.
11. Archer T, Fredriksson A, Jonsson G, Lewander T, Mohammed AK, Söderberg U. 1986. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. Psychopharmacology 88:141-146 DOI 10.1007/BF00652230.
12. Archer T, Johansson B, Fredriksson A. 2011. Exercise alleviates Parkinsonism: clinical and laboratory evidence. ACTA Neurologica Scandinavica 123(2):73-84 DOI 10.1111/j.1600-0404.2010.01360.x.
13. Björk L, Lindgren S, Hacksell U, Lewander T. 1991. (S)-UH-301 antagonises R-8OH-DPATinduced cardiovascular effects in the rat. European Journal of Pharmacology 199:367-370 DOI 10.1016/0014-2999(91)90502-H.
14. Cerasa A, Fasano A, Morgante F, Koch G, Quattrone A. 2014. Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology. Frontiers in Neurology 9(5):49 eCollection 2014 DOI 10.3389/fneur.2014.00049.
15. Cheng SP, Yang CY, Tang FI, Chen IJ. 2013. Training effects of a 12-week walking program on Parkinson disease patients and community-dwelling older adults. NeuroRehabilitation 32(4):967-976 DOI 10.3233/NRE-130920.
16. Cholewa J, Boczarska-Jedynak M, Opala G. 2013. Influence of physiotherapy on severity of motor symptoms and quality of life in patients with Parkinson disease. Neurologia I Neurochirurgia Polska 47(3):256-262 DOI 10.5114/ninp.2013.35774.
17. Earhart GM, Falvo MJ. 2013. Parkinson disease and exercise. Comprehensive Physiology 3(2):833-848 DOI 10.1002/cphy.c100047.
18. Eriksson BM, Arne M, Ahlgren C. 2013. Keep moving to retain the healthy self: the meaning of physical exercise in individuals with Parkinson's disease. Disability and Rehabilitation 35(26):2237-2244 DOI 10.3109/09638288.2013.775357.
19. Fredriksson A, Stigsdotter IM, Hurtig A, Ewalds-Kvist B, Archer T. 2011. Running wheel activity restores MPTP-induced functional deficits. Journal of Neural Transmission 118(3):407-420 DOI 10.1007/s00702-010-0474-8.
20. Gedymin LE, Golant MB, Kuznetsov AP, Mudrik DG, Kolpikova TV, Balakireva LZ. 1999. The use of yeast living cells as a biological retranslation media for the therapeutic EHF effects. Millimeter Waves Biology and Medicine 16:10-15 (in Russian).
21. Golant MB. 1994. Physical laws of medicine and their use in the realization of living organisms with EHF radiation. Radiophysics and Quantum Electronics 37:45-47 DOI 10.1007/BF01039300.
22. Golant MB, Mudrik DG, Kruglyakova OP, Izvol'skaya VE. 1994. Effect of EHF-radiation polarization on yeast cells. Radiophysics and Quantum Electronics 37:82-84 DOI 10.1007/BF01039307.
23. Grazina R, Massano J. 2013. Physical exercise and Parkinson's disease: influence on symptoms, disease course and prevention. Reviews in the Neurosciences 24(2):139-152 DOI 10.1515/revneuro-2012-0087.
24. Kirk R. 1995. Experimental design: procedures for the behavioral sciences. Belmont: Brooks/Cole.
25. Kolosova LI, Akoev GN, Ryabchikova OV, Avelev VD. 1998. Effect of low-intensity millimeter-range electromagnetic irradiation on the recovery of function in lesioned sciatic nerves in rats. Neuroscience and Behavioral Physiology 28:26-30 DOI 10.1007/BF02461908.
26. Liu Y, Yu H, Mohell N, Nordvall G, Lewander T, Hachsell U. 1995. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-antagonists. Journal of Medicinal Chemistry 38:150-160 DOI 10.1021/jm00001a020.
27. Park CY, Lee SH, Kim BK, Shin MS, Kim CJ, Kim H. 2013. Treadmill exercise ameliorates impairment of spatial learning ability through enhancing dopamine expression in hypoxic ischemia brain injury in neonatal rats. Journal of Exercise Rehabilitation 9(4):406-412 DOI 10.12965/jer.130053.
28. Park A, Zid D, Russell J, Malone A, Rendon A, Wehr A, Li X. 2014. Effects of a formal exercise program on Parkinson's disease: a pilot study using a delayed start design. Parkinsonism & Related Disorders 20(1):106-111 DOI 10.1016/j.parkreldis.2013.10.003.
29. Pietracupa S, Latorre A, Berardelli A, Fabbrini G. 2014. Parkinsonian patients and poor awareness of dyskinesias. Frontiers in Neurology 5:32 eCollection 2014.
30. Ragimov CR, Ter-Asturov GP, Golant MB, Rogov KA, Balakireva LZ. 1991. Stimulation of reparative osteogenesis by millimeter band electromagnetic radiation in experimental traumatic defects of the mandible. Bulletin of Experimental Biology and Medicine 111:562-565 DOI 10.1007/BF00841505.
31. Rose MH, Løkkegaard A, Sonne-Holm S, Jensen BR. 2013. Improved clinical status, quality of life, and walking capacity in Parkinson's disease after body weight-supported high-intensity locomotor training. Archives of Physical Medicine and Rehabilitation 94(10):2033 DOI 10.1016/j.apmr.2013.03.031.
32. Shin E, Rogers JR, Devoto P, Björklund A, Carta M. 2014. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Experimental Neurology 257:25-38 DOI 10.1016/j.expneurol.2014.04.011.
33. Wang Z, Myers KG, Guo Y, Ocampo MA, Pang RD, Jakowec MW, Holschneider DP. 2013. Functional reorganization of motor and limbic circuits after exercise training in a rat model of bilatera parkinsonism. PLoS ONE 8(11):e80058 DOI 10.1371/journal.pone.0080058.
34. Zheng X, Takatsu S, Wang H, Hasegawa H. 2014. Acute intraperitoneal injection of caffeine improves endurance exercise performance in association with increasing brain dopamine release during exercise. Pharmacology, Biochemistry and Behavior 122C:136-143 DOI 10.1016/j.pbb.2014.03.027.
35. Zigmond MJ, Smeyne RJ. 2014. Exercise: is it a neuroprotective and if so, how does it work? Parkinsonism & Related Disorders 20(Suppl 1):S123-S127 DOI 10.1016/S1353-8020(13)70030-0.